Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 95

Results For "2022"

1438 News Found

Sadhana Nitro Chem commences production of its 1st para aminophenol plant
News | June 22, 2022

Sadhana Nitro Chem commences production of its 1st para aminophenol plant

The company is now introducing the product into the India pharmaceutical market.


Aurobindo Pharma board approves acquisition of GLS Pharma
News | June 20, 2022

Aurobindo Pharma board approves acquisition of GLS Pharma

The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.


Aether Industries Q4 FY22 revenue up 26.8%; Profit up 13.8%
News | June 18, 2022

Aether Industries Q4 FY22 revenue up 26.8%; Profit up 13.8%

Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21


GlycoEra AG appoints Tanmoy Ganguly as Chief Scientific Officer
People | June 17, 2022

GlycoEra AG appoints Tanmoy Ganguly as Chief Scientific Officer

Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics


COVID-19 infected 9-year-child successfully gets a heart transplant at Masinda Heart Institute
Healthcare | June 16, 2022

COVID-19 infected 9-year-child successfully gets a heart transplant at Masinda Heart Institute

Many kids who have heart transplants live a normal, healthy life once they recover from surgery.


LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA
News | June 16, 2022

LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA

With this designation, LG Chem will receive benefits such as exclusive sales rights in the US market for seven years, subsidies and tax cuts for clinical testing costs in the US, and preliminary consulting support related to development


ADC Therapeutics appoints David Gilman as Chief Business & Strategy Officer
People | June 15, 2022

ADC Therapeutics appoints David Gilman as Chief Business & Strategy Officer

Gilman will be responsible for all business development and portfolio strategy efforts globally.


Etihad Cargo signs MOU for sustainable pharmaceutical transportation solutions
Supply Chain | June 15, 2022

Etihad Cargo signs MOU for sustainable pharmaceutical transportation solutions

Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals


CCI approves sale of biosimilars portfolio of Viatris to Biocon Biologics
News | June 15, 2022

CCI approves sale of biosimilars portfolio of Viatris to Biocon Biologics

The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics


NHA and NASSCOM organised a conclave on Ayushman Bharat Digital Mission
Policy | June 15, 2022

NHA and NASSCOM organised a conclave on Ayushman Bharat Digital Mission

The Ayushman Bharat Digital Mission (ABDM) aims to replicate this success in healthcare delivery by building an equitable, accessible and inclusive ecosystem